$2.5m placement
Filed with ASX · · 4 pages · English
Story so far
Earlier from AdAlta
- BZDS1901 manufacturing agreement
- Automated cell therapy manufacturing MoU
- BZDS1901 clinical update
- AdCella and SHcell hold first JDC meeting
- New AD-214 patent granted
Later from AdAlta
- Regulatory advisors appointed for BZDS1901
- Second BZDS1901 milestone paid
- Oktopi AI collaboration for research efficiency
- 2 year survival milestone for EW-001 patient
- EW-001 IIT study overall survival update
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta